GenScript is a global biotechnology company founded in 2002, specializing in gene synthesis technology and associated services that support life sciences research and drug development. The company maintains a workforce of over 5,700 employees and serves more than 200,000 customers across 100+ countries, with operations spanning North America, Europe, Greater China, and the Asia Pacific region.
The company's technical capabilities cover a broad range of domains including gene synthesis, molecular biology, antibody production, protein expression and purification, enzyme and synthetic biology, biologics development and manufacturing, and cell therapy solutions. GenScript operates as both a life science contract research organization (CRO) and a contract development and manufacturing organization (CDMO), offering services from early-stage research through biologics manufacturing.
GenScript's product and service portfolio spans enzyme and synthetic biology products, biologics development and manufacturing services, and cell therapy solutions. The company's stated mission is to make humans and nature healthier through biotechnology, with a corporate vision of becoming the most reliable biotech company in the world.
